Pivotal roles of regulating the proline-rich tyrosine kinase 2 (PYK2) signaling in cardiac function and remodeling

Journal of Molecular and Cellular Cardiology

Volumn 74, Issue , 2014, Pages 295-296

  Takeishi, Yasuchika ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ATRIAL NATRIURETIC FACTOR; FOCAL ADHESION KINASE 2; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; PHOSPHOLAMBAN; PROTEIN KINASE C EPSILON; PROTEIN TYROSINE KINASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; TROPONIN I;

AUTOPHOSPHORYLATION; CARBOXY TERMINAL SEQUENCE; CORONARY ARTERY LIGATION; CRNK GENE; DISEASE COURSE; ECHOCARDIOGRAPHY; EDITORIAL; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; GENE; GENE EXPRESSION; GENE TRANSFER; GENETIC ENGINEERING; GENOTYPE; HEART CATHETERIZATION; HEART CONTRACTION; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MECHANICAL STRESS; MYOFILAMENT; NONHUMAN; NUCLEOTIDE BINDING SITE; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; SERCA2 GENE; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CONGESTIVE CARDIOMYOPATHY; GENETICS; HEART VENTRICLE FUNCTION; METABOLISM; PHYSIOLOGY; TRANSGENE;

ANIMALS; CARDIOMYOPATHY, DILATED; FOCAL ADHESION KINASE 2; MYOCYTES, CARDIAC; TRANSGENES; VENTRICULAR FUNCTION; VENTRICULAR REMODELING;

EID: 84904740152     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.06.005     Document Type: Editorial

References (17)

1. Avraham H., Park S.Y., Schinkmann K., Avraham S. RAFTK/Pyk2-mediated cellular signaling. Cell Signal 2000, 12:123-133.
2. Blaukat A., Ivankovic-Dikic I., Grönroos E., Dolfi F., Tokiwa G., Vuori K., et al. Adaptor proteins Grb2 and Crk couple Pyk2 with activation of specific mitogen-activated protein kinase cascades. J Biol Chem 1999, 274:14893-14901.
3. Park S.Y., Avraham H.K., Avraham S. RAFT/Pyk2 activation is mediated by trans-acting autophosphorylation in a Src-independent manner. J Biol Chem 2004, 279:33315-33322.
4. Bayer A.L., Heidkamp M.C., Howes A.L., Brown J.H., Byron K.L., Samarel A.M. Protein kinase Cε-dependent activation of proline-rich tyrosine kinase 2 in neonatal rat ventricular myocytes. J Mol Cell Cardiol 2003, 35:1121-1133.
5. Bayer A.L., Ferguson A.G., Lucchesi P.A., Samarel A.M. PYK2 expression and phosphorylation in neonatal and adult cardiomyocytes. J Mol Cell Cardiol 2001, 33:1017-1030.
6. Bayer A.L., Heidkamp M.C., Patel N., Porter M.J., Engman S.J., Samarel A.M. PYK2 expression and phosphorylation increases in pressure overload-induced left ventricular hypertrophy. Am J Physiol Heart Circ Physiol 2002, 283:H695-H706.
7. Lang D., Glukhov A.V., Efimova T., Efimova I.R. Role of Pyk2 in cardiac arrhythmogenesis. Am J Physiol Heart Circ Physiol 2011, 301:H975-H983.
8. Xiong W.C., Macklem M., Parsons J.T. Expression and characterization of splice variants of PYK2, a focal adhesion kinase-related protein. J Cell Sci 1998, 111:1981-1991.
9. Li X., Dy R.C., Cance W.G., Graves L.M., Earp H.S. Interactions between two cytoskeleton-associated tyrosine kinase: calcium-dependent tyrosine kinase and focal adhesion tyrosine kinase. J Biol Chem 1999, 274:8917-8924.
10. Hart D.L., Heidkamp M.C., Lyengar R., Vijayan K., Szotek E.L., Barakat J.A., et al. CRNK gene transfer improves function and reverses the myosin heavy chain isozymes switch during post-myocardial infarction left ventricular remodeling. J Mol Cell Cardiol 2008, 45:93-105.
11. Koshman Y.E., Chu M., Kim T., Kalmanson O., Fajah M., Kuma M., et al. Cardiomyocyte-specific expression of CRNK, the C-terminal domain of PYK2, maintains ventricular function and slows ventricular remodeling in a mouse model of dilated cardiomyopathy. J Mol Cell Cardiol 2014, 72:281-291.
12. Goldspink P.H., Montgomery D.E., Walker L.A., Urboniene D., McKinney R.D., Geenen D.L., et al. Protein kinase Cε overexpression alters myofilament properties and composition during the progression of heart failure. Circ Res 2004, 95:424-432.
13. Takeishi Y., Ping P., Bolli R., Kirkpatrick D.L., Hoit B.D., Walsh R.A. Transgenic overexpression of constitutively active protein kinase Cε causes concentric cardiac hypertrophy. Circ Res 2000, 86:1218-1223.
14. Heidkamp M.C., Scully B.T., Vijayan K., Engman S.J., Szotek E.L., Samarel A.M. PYK2 regulates SERCA2 gene expression in neonatal rat ventricular myocytes. Am J Physiol Cell Physiol 2005, 289:C471-C482.
15. Morkin E. Regulation of myosin heavy chain genes in the heart. Circulation 1993, 87:1451-1460.
16. Scruggs S.B., Walker L.A., Lyu T., Geenen D.L., Solaro R.J., Buttrick P.M., et al. Partial replacement of cardiac troponin I with a non-phosphorylatable mutant at serines 43/45 attenuates the contractile dysfunction associated with PKCε phosphorylation. J Mol Cell Cardiol 2006, 40:465-473.
17. 2+-sensitive isoforms in the failing human heart. Circulation 1999, 99:384-391.